Clinical trials
Observational Pulmonary Edema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 15 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 3 |
| Dalarna County Council, Sweden | 2 |
| Massachusetts General Hospital | 2 |
| Progenity, Inc. | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| Ain Shams Maternity Hospital | 1 |
| Ankara University | 1 |
| Bicetre Hospital | 1 |
| Biotronik SE & Co. KG | 1 |
| Cardioflow Technologies, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Edema | 47 |
| Heart Failure | 7 |
| Pneumonia | 7 |
| Respiratory Distress Syndrome | 7 |
| Hypertension | 6 |
| Pre-Eclampsia | 5 |
| Renal Insufficiency | 5 |
| Dyspnea | 4 |
| Edema | 4 |
| Lung Diseases | 4 |
Trials
Showing 76 to 47 of 47. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.